How to Fill Out FDA Form 3500A (w/Examples) + FAQs

FDA Form 3500A is the official mandatory reporting form that manufacturers, importers, user facilities, and responsible persons must submit when they learn of serious adverse events, product problems, or device malfunctions linked to FDA-regulated products. Unlike Form 3500 (for voluntary reports), Form 3500A carries legal obligations under federal regulations including 21 CFR Part 314.80 for drugs, 21 CFR Part 803 for medical devices, and Section 761 of the FD&C Act for dietary supplements.

Failing to submit required reports can trigger severe consequences. The FDA has assessed civil money penalties and pursued criminal prosecution against companies that neglect these obligations. One medical device company paid $92.4 million in criminal and civil fines after failing to report 12 patient deaths and 57 emergency procedures, demonstrating DOJ’s aggressive enforcement philosophy regarding adverse event reporting. The FDA’s FAERS database now receives over 2 million adverse event reports annually, making accurate documentation essential for public health surveillance.

Here’s what you’ll learn in this article:

📋 How to complete each section (A through H) of Form 3500A with field-by-field guidance and real-world examples

⏰ The specific deadlines for drugs (15 days), devices (5, 10, or 30 days), dietary supplements (15 business days), and cosmetics (15 business days)

⚠️ Common mistakes that cause report rejections—and how to avoid them

💻 When to use paper forms versus electronic submission through the Safety Reporting Portal or E2B gateway

❓ Answers to the most frequently asked questions about mandatory adverse event reporting requirements

Who Must Use FDA Form 3500A?

Form 3500A serves a specific group of mandatory reporters. The distinction between voluntary (Form 3500) and mandatory (Form 3500A) reporting is critical because using the wrong form can delay safety signal detection. The FDA published clear guidance separating these categories based on legal obligations rather than personal choice.

Mandatory reporters who must use Form 3500A include:

Healthcare professionals and consumers who voluntarily report should use Form 3500 or 3500B instead. The mandatory form contains additional sections on the back page that collect manufacturer-specific and user facility-specific information not needed for voluntary reports.

What Triggers a Mandatory Report?

A “serious adverse event” under FDA definitions results in specific patient outcomes that distinguish reportable events from minor reactions. Understanding these triggers prevents both under-reporting (a compliance violation) and over-reporting (which wastes resources). The FDA uses identical seriousness criteria across most product categories with minor variations for cosmetics.

For cosmetics specifically, the MoCRA legislation added two additional outcomes: infections and significant disfigurement (including serious persistent rashes, second- or third-degree burns, and significant hair loss). These categories became enforceable on December 29, 2023.

Reporting Deadlines by Product Type

Missing a deadline transforms a regulatory obligation into a compliance violation. Different product categories operate under different timeframes established by their governing regulations. The clock starts when any employee of the company receives information suggesting a reportable event occurred.

Follow-up reports also carry deadlines. For drugs, new information on previously reported events must be submitted within 15 days of receipt. Dietary supplement and cosmetics manufacturers who receive additional material information within one year of the initial report must submit it within 15 business days.

Section-by-Section Guide to Completing Form 3500A

Section A: Patient Information

Section A identifies the individual who experienced the adverse event. The FDA holds patient identity in strict confidence and protects it under the fullest extent of the law. Never use the patient’s actual name, Social Security number, or medical record number—only initials or an internal code that allows your organization to locate records if FDA requests follow-up.

A1: Patient Identifier
Enter initials or an internal tracking code. If no patient was involved (such as a product quality problem discovered during manufacturing), enter “none.”

A2: Age or Date of Birth
Provide the patient’s birth date if known, or their age at event onset. The FDA requires specific age units based on the patient’s life stage. Patients 3 years or older should be reported in years. Children under 3 years should be reported in months. Infants under 1 month should be reported in days.

A3: Sex
Select male, female, or unknown. For congenital anomalies, report the sex of the child, not the mother.

A4: Weight
Enter weight in pounds or kilograms, marking which unit you used. Estimate if the exact weight is unknown.

Scenario: Completing Section A for a Drug Reaction

Section B: Adverse Event or Product Problem

Section B captures what happened. This section determines whether the event qualifies as serious and which outcome categories apply. The detailed narrative in B5 often proves most valuable for FDA safety reviewers attempting to understand causation.

B1: Type of Report
Check “Adverse Event” if a patient experienced harm. Check “Product Problem” if reporting a defect, malfunction, or quality issue. Check both if a product problem caused patient harm.

B2: Outcomes Attributed to Adverse Event
Check all outcomes that apply—this is not single-select. The checkboxes mirror the serious adverse event definition:

• Death: Only check if the death was suspected to be caused by the product. Include the death date if known.
• Life-threatening: Check if the patient was at substantial risk of dying at the time of the event.
• Hospitalization: Check for initial hospital admission or prolonged stay. Emergency room visits count only if they result in admission.
• Disability or Permanent Damage: Check for substantial disruption of normal life functions.
• Congenital Anomaly/Birth Defect: Check if prenatal exposure may have caused the defect.
• Required Intervention: Check if medical or surgical treatment was needed to prevent permanent damage.
• Other Serious: Use for events that don’t fit above but may jeopardize the patient (e.g., drug dependence, allergic bronchospasm treated in ER).

B3: Date of Event
Enter the date when the adverse event first started, not when it was reported. Use dd-mmm-yyyy format (e.g., 15-Jan-2026). If the day is unknown, month and year are acceptable. For congenital anomalies, use the child’s birth date.

B4: Date of This Report
Enter the date you are submitting this report to FDA.

B5: Describe Event or Problem
This narrative field requires clinical detail. Use the reporter’s own words and include:

• Medical status before the event
• Signs, symptoms, and clinical course
• Differential diagnosis considerations
• Treatment provided
• Patient outcome

For cosmetics, include the amount and frequency used, which body parts the product contacted, and the specific outcomes observed. For device problems, describe the malfunction circumstances in detail.

B6: Relevant Test/Laboratory Data
Include baseline labs from before product use, diagnostic tests used to identify the event, and follow-up results. Negative findings are also valuable—they help rule out other causes.

B7: Other Relevant History
List preexisting medical conditions, allergies, smoking status, pregnancy status, and other factors that might affect interpretation.

Scenario: Completing Section B for a Device Malfunction

Section C: Suspect Product(s)

Section C identifies the drug, biologic, dietary supplement, or cosmetic suspected of causing the event. Up to two suspect products can appear on one form. If three or more products are suspected, attach additional 3500A forms with only Section C completed.

C1: Name, Strength, Manufacturer/Compounder
Enter the product name exactly as it appears on the label. Include:

• Trade/brand name or generic name
• Strength and unit (e.g., 500 mg)
• NDC number or unique identifier
• Manufacturer name
• Lot number

For HCT/Ps (human cells, tissues, cellular and tissue-based products), include the tissue type and establishment registration number.

C2: Dose, Frequency & Route Used
Describe exactly how the patient used the product. Include dose amount, frequency (e.g., twice daily), and route (e.g., oral, topical, intravenous). If an overdose occurred, specify the amount taken.

C3: Therapy Start and Stop Dates
Provide the dates the patient started and stopped using the product, or the best estimate of treatment duration.

C4: Diagnosis for Use
State why the product was being used (e.g., “hypertension,” “joint pain relief”).

C5: Product Type
Check applicable categories. For cosmetics, indicate whether professional-use or retail product.

C6: Expiration Date
Especially important for product quality problems or HCT/Ps.

C7: Event Abated After Use Stopped or Dose Reduced
Check “Yes” if symptoms improved when the patient stopped or reduced the product. This information supports causality assessment.

C8: Event Reappeared After Reintroduction
Check “Yes” if symptoms returned when the patient resumed using the product. This is strong evidence of product-event relationship.

C9: Concomitant Products
List other medical products the patient was using at the same time (not treatments given for the event).

Example: Completing Section C for a Dietary Supplement

Section D: Suspect Medical Device

Section D replaces Section C when a medical device is the suspect product. This section captures device-specific identifiers that enable lot-level traceability. The information should match data in FDA’s GUDID database when available.

D1: Brand Name
Enter the device brand name exactly as shown on labeling.

D2a: Procode
The Procode is FDA’s product classification code. Search FDA’s device database or contact FDA if uncertain.

D2b: Common Device Name
Use the generic device name (e.g., “urological catheter,” not just “catheter”).

D3: Manufacturer Name, City, State and Country
Enter complete manufacturer information. If the device was reprocessed, enter the reprocessor’s information instead—the reprocessor becomes the manufacturer for regulatory purposes.

D4: Model #, Lot #, Catalog #, Serial #, Expiration Date, UDI #
Copy all identification numbers exactly as they appear on the device label, including spaces, hyphens, and special characters. The UDI (Unique Device Identifier) is particularly important—it enables comprehensive device tracking. The UDI begins with one of three prefixes: (01), +, or 0.

D5: Operator of Device
Indicate who was operating the device: health professional, patient/lay user, or other.

D6a/D6b: Implant and Explant Dates
If the device was implanted, provide that date. If it was later removed (explanted), provide that date as well.

D7a/D7b: Single-Use Reprocessing
Indicate whether this single-use device was reprocessed for reuse. If yes, identify the reprocessor.

D8: Third-Party Service
Indicate if the device was ever serviced by a third party.

D9: Device Available for Evaluation?
Check “Yes” if the device is available for analysis. Provide the date it can be returned. Do not send devices to FDA unless specifically requested.

D10: Concomitant Medical Products
List other devices or products in use at the time.

Section E: Initial Reporter

Section E identifies the person who first reported the event—often a healthcare provider, patient, or family member. This is not the manufacturer employee completing the form. The FDA may need to contact this person for follow-up information about the clinical course.

E1: Name and Address
Provide the initial reporter’s full contact information including phone and email.

E2: Health Professional?
Indicate whether the initial reporter is a healthcare professional (physician, nurse, pharmacist, etc.) or a layperson.

E3: Occupation
Select the reporter’s occupation from the provided list.

E4: Initial Reporter Also Sent Report to FDA
Indicate if the initial reporter already submitted their own report directly to FDA. This helps avoid duplicate counting.

Section F: For User Facilities/Importers (Devices Only)

Section F is completed only by device user facilities (hospitals, nursing homes, ambulatory surgical facilities) and device importers. Manufacturers skip this section.

F1: Check One
Identify your organization as either a User Facility or an Importer.

F2: User Facility/Importer Report Number
Enter your unique report number in the required format. User facilities use their HCFA number, the 4-digit year, and a sequential 4-digit number (e.g., 1234567890-2026-0001). Importers use their FDA registration number.

F6: Date Became Aware of Event
Enter the date your facility first learned of the event. This starts your 10-work-day deadline.

F7: Type of Report
Indicate whether this is an initial report or a follow-up (and which follow-up number).

F9: Adverse Event Problem
Enter up to 3 Patient Problem codes and 3 Device Problem codes using FDA’s MDR coding manual.

F10: Report Sent to FDA?
Indicate whether and when you submitted to FDA.

F12: Report Sent to Manufacturer?
For serious injuries, user facilities must report to the manufacturer (or to FDA if manufacturer is unknown). Indicate the date sent.

Scenario: User Facility Reporting a Device Death

Section G: All Manufacturers and Responsible Persons

Section G applies to all mandatory reporters—drug/biologic manufacturers, device manufacturers, dietary supplement responsible persons, and cosmetics responsible persons. This section provides manufacturer-level information critical for FDA’s database organization.

G1: Contact Office
Provide your company’s regulatory contact office name, address, phone, and email. For devices, also include the manufacturing site information.

G2: Report Source
Check how you received this report:

• Foreign
• Study (clinical trial)
• Literature (attach the article)
• Consumer
• Health Professional
• User Facility
• Company Representative
• Distributor
• Other

G3: Date Received by Manufacturer
Enter the date your company first received information about this event. This date starts your reporting deadline.

G4: Application Numbers
Enter your NDA, ANDA, BLA, IND, PMA, 510(k), or other application numbers as applicable.

G6: Type of Report
Indicate report category:

• For drugs: 15-day, Periodic, IND
• For devices: 5-day, Initial, Follow-up
• Check Initial or Follow-up and indicate sequence number

G7: Adverse Event Term(s)
List the adverse event terms using MedDRA preferred terms when possible. List the most clinically significant term first.

G8: Manufacturer Report Number
Enter your unique report number matching the format for your product type.

Section H: Device Manufacturers Only

Section H contains additional fields required exclusively from device manufacturers.

H1: Type of Reportable Event
Indicate whether reporting: Death, Serious Injury, Malfunction, or Summary report.

H3: Device Evaluated by Manufacturer?
Indicate whether your company analyzed the returned device. If yes, summarize findings in H11. If no, explain why not.

H6: Adverse Event Problem
Enter additional codes: Health Effect-Clinical codes, Health Effect-Impact codes, Device Problem codes, and Investigation codes.

H7: Remedial Action Initiated
If your company took corrective action (recall, repair, relabeling, notification, inspection, replacement, modification/adjustment), check applicable boxes.

H10: Related Report Number
If you know of related MDR reports (such as the user facility’s report number), enter them here for cross-referencing.

H11: Additional Manufacturer Narrative
Use this space for supplemental information including device evaluation results, engineering analysis, corrective action details, and cross-reference to other reports.

Electronic Submission Options

The FDA strongly encourages—and in many cases requires—electronic submission. Paper forms are permitted only when electronic submission is unavailable. Two electronic pathways exist for mandatory reporters.

Option A: Database-to-Database Transmission (E2B)

Large pharmaceutical and device companies typically submit through the Electronic Submission Gateway (ESG) using XML format. As of January 16, 2024, FDA accepts the ICH E2B(R3) standard. All submitters must implement E2B(R3) by April 1, 2026. Once your company begins submitting in E2B(R3), you cannot revert to older methods.

Option B: Safety Reporting Portal (SRP)

Companies without E2B capability can use the FDA Safety Reporting Portal for manual web-based entry. To establish an SRP account:

1. Email [email protected] expressing intent to submit via SRP
2. Complete the registration form
3. Wait 7-10 business days for account activation
4. Receive email with login credentials and portal link

The SRP walks users through a questionnaire format mirroring Form 3500A fields. It includes built-in validation checks to ensure data quality before submission.

Cosmetics Reporting

FDA is currently developing electronic cosmetics reporting capability. Until the portal is updated, cosmetics responsible persons should email completed Form 3500A to [email protected] or mail to FDA CDER Mail Center, Attn: Cosmetics MedWatch reports, White Oak Campus, Building 22, G0207, 10903 New Hampshire Ave., Silver Spring, MD 20993.

Mistakes to Avoid

Common errors cause report rejections, follow-up requests, and compliance findings during FDA inspections. Each mistake creates additional work and may delay important safety signals.

Data entry errors represent a documented problem in the FAERS database. Misspelled drug names create fragmented records that impair signal detection. Always verify product names against labeling before submission.

Do’s and Don’ts

Special Situations

Multiple Patients Affected by One Device

When a single device affects multiple patients simultaneously (such as a contaminated reusable scope), user facilities can report on one primary form with additional 3500A attachments. The primary form should be complete. Each attachment needs only Sections A, B2, B5-B7, D10, F2, and F10 completed. Indicate the total patient count in B5 narrative. All forms must share the same user facility report number.

Mother-Infant Reports

When a mother’s product exposure affects a fetus or nursing infant, reporting rules depend on who experienced the event:

• If only mother affected: Report mother as patient
• If only infant/fetus affected (except fetal death/miscarriage): Report infant as patient; Section C/D applies to mother’s exposure
• Fetal death/miscarriage/abortion: Report mother as patient
• Both affected: Submit two linked reports

Literature-Based Reports

Device manufacturers who learn of reportable events through published literature must report. The event date becomes the publication date. The report date becomes the date an employee first saw the literature. Attach a copy of the article (translated to English if necessary).

Frequently Asked Questions

Can I submit Form 3500A as a PDF email attachment?
No. Electronic submission must go through the Safety Reporting Portal or ESG gateway. Email submission is permitted only for cosmetics reports to [email protected] until the electronic portal is updated.

Do I need to report events that occurred outside the United States?
Yes. Manufacturers must report serious adverse events regardless of where they occurred if the product is marketed in the U.S. under 21 CFR 314.80 and 803.

Is there a penalty for late reporting?
Yes. FDA can issue warning letters, seek injunctions, assess civil money penalties, or pursue criminal prosecution for failure to report or late reporting.

Can a user facility be held liable for what they report?
No. Federal law under 21 USC 360i(b)(3) provides that user facility reports cannot be used in private civil litigation unless the reporter knowingly included false information.

Do I report adverse events during clinical trials on Form 3500A?
Yes. IND sponsors may use Form 3500A for IND safety reports, or submit in narrative format or electronically per 21 CFR 312.32.

What if I don’t know the lot number?
No. Submit with available information and note “unknown” for missing fields. Follow up when additional information becomes available.

Must dietary supplement retailers file reports?
No. Only the “responsible person” (manufacturer, packer, or distributor whose name appears on the label) must file mandatory reports.

Can consumers use Form 3500A?
No. Consumers should use Form 3500B for voluntary reporting. Form 3500A is for mandatory industry reporters only.

How long must I keep adverse event records?
Yes. Drug manufacturers must retain records for 10 years. Dietary supplement and cosmetics companies must retain for 6 years. Device user facilities must retain for 2 years.

Does reporting admit that my product caused the event?
No. The form explicitly states that submission does not constitute admission that the product caused or contributed to the event. Cosmetics manufacturers may include a denial statement with their report.